AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N92020C00033UBIQUITOME LIMITED
Overview
Award facts
- Net obligations
- $1.46M
- $1,462,373of $1.46M potential value
- Outlays (paid to date)
- $1.46M
- $1.46M paid of $1.46M obligated$1,462,373
- Period of performance
- Sep 29, 2020 to Apr 16, 2021
- Ended
- Modifications
- 2
- Latest action Nov 30, 2021
- Contract type
- Definitive contract
- PIID 75N92020C00033
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
RADX TECH PROJECT #4554: UBIQUITOME SARS-COV-2 LAB TEST ACCURACY WITHIN REACH OF EVERY AMERICAN WITH LIBERTY16 MOBILE REAL TIME PCR
Dates and value
- Award date
- Signed on Sep 29, 2020
- Potential end of performance
- Apr 29, 2021
- Current value
- $1,462,373Base and exercised options
- Potential value (if all options are exercised)
- $1,462,373
Obligations by fiscal year of action
- FY2022: -$997,627 (de-obligation)
- FY2021: $1,760,000
- FY2020: $700,000
Total across 3 fiscal years: $1,462,373
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 30, 2021. View on USAspending · Recipient on SAM.gov
Recipient
LocationAUCKLAND, NZL
UEIDGS8FJVKUM33
CAGE codeEBNE8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyUBIQUITOME LIMITED
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIBIB
- Funded from
- Public health and social services emergency fund; National institute of biomedical imaging and bioengineering (0898)Program activities075-0140, 075-0898Federal accounts (agency financial reports)
Place of performance
- Place of performance
- New Zealand
Classification and competition
Classification
- Product or service (PSC)
- Q301MEDICAL- LABORATORY TESTING (service)
Competition
- Extent competed
- Not available for competitionB
- Reason not competed
- Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Rapid acceleration of diagnostics (RADX)
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 29, 2020Base obligation at award: $700,000
- Latest action
- Nov 30, 2021 — Terminated for convenienceModification P00002; obligation change -$997,627
- Latest substantive action
- Nov 30, 2021 — Terminated for convenienceModification P00002; obligation change -$997,627
- Actions by type
- Base award1
- Terminated for convenience1
- Letter contract definitized1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$997,627
- Latest action: change in base and all options
- -$997,627
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- National interest action
- COVID-19 2020P20C
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
- Country of product or service origin
- New zealandNZL
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N920
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N92D
- Treasury accounts
- 075-X-0140-000
- 075-X-0898-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- P: Emergency P.L. 116-139
- COVID-19 supplemental obligations
- $1,462,373
- COVID-19 supplemental outlays
- $1,462,373